RecruitingPhase 1NCT06451497
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Sponsor: Zumutor Biologics Inc.
Austin, TX 78758, TX · San Antonio, TX · +1 more sites